|
ZNF484 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63813407283442E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.62779797921553E-11 |
| Normal-vs-Stage2 |
1.1728000004485E-07 |
| Normal-vs-Stage3 |
4.87569984386482E-11 |
| Normal-vs-Stage4 |
3.86729981372014E-10 |
| Stage1-vs-Stage2 |
3.797600E-01 |
| Stage1-vs-Stage3 |
1.746040E-01 |
| Stage1-vs-Stage4 |
5.416400E-02 |
| Stage2-vs-Stage3 |
9.129800E-01 |
| Stage2-vs-Stage4 |
4.138800E-01 |
| Stage3-vs-Stage4 |
4.046000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.64699978286865E-10 |
| Normal-vs-AfricanAmerican |
1.619520E-02 |
| Normal-vs-Asian |
2.38239999994505E-06 |
| Caucasian-vs-AfricanAmerican |
2.050100E-02 |
| Caucasian-vs-Asian |
4.836000E-01 |
| AfricanAmerican-vs-Asian |
1.731590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.8486990544252E-11 |
| Normal-vs-Female |
1.81998860426802E-12 |
| Male-vs-Female |
5.960200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.1006999473272E-09 |
| Normal-vs-Age(41-60Yrs) |
2.25763852057526E-12 |
| Normal-vs-Age(61-80Yrs) |
1.04469999318013E-09 |
| Normal-vs-Age(81-100Yrs) |
2.049900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.727170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.197240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.124240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.801600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.340400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.739400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.561600E-02 |
| Classical-VS-Follicular |
5.583700E-02 |
| Classical-VS-Other |
3.641800E-01 |
| Classical-VS-Normal |
7.94469999787495E-08 |
| Tall-VS-Follicular |
5.392400E-01 |
| Tall-VS-Other |
9.315400E-01 |
| Tall-VS-Normal |
3.1257999522083E-09 |
| Follicular-VS-Other |
7.960600E-01 |
| Follicular-VS-Normal |
2.22920015779948E-10 |
| Other-VS-Normal |
3.237300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.13931086787034E-12 |
| Normal-vs-N1 |
5.18289999806854E-08 |
| N0-vs-N1 |
7.780000E-01 |
|
|
